Intra-cellular Therapies, Inc. logo

Intra-cellular Therapies, Inc. share price today

(ITCI)

Intra-cellular Therapies, Inc. share price is $84.55 & ₹7,156.57 as on 7 Dec 2024, 2.30 'hrs' IST

$84.55

▲

0.46

(0.55%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Intra-cellular Therapies, Inc. share price in Dollar and Rupees. Guide to invest in Intra-cellular Therapies, Inc. from India. Also see the sentimental analysis on Indian investors investing in Intra-cellular Therapies, Inc.. Get details on the Indian mutual funds that are investing in Intra-cellular Therapies, Inc.. Get Analyst recommendations and forecasts along with all the Intra-cellular Therapies, Inc.'s financials.

Intra-cellular Therapies, Inc. share price movements

  • $83.46
    $84.71

    Day's Volatility :1.48%

  • $58.93
    $93.45

    52 Weeks Volatility :36.94%

Intra-cellular Therapies, Inc. Returns

PeriodIntra-cellular Therapies, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
13.01%
-5.7%
0.0%
6 Months
21.75%
-0.8%
0.0%
1 Year
39.48%
9.9%
0.0%
3 Years
114.68%
10.7%
-19.7%

Intra-cellular Therapies, Inc. Key Statistics

in dollars & INR

Previous Close
$84.09
Open
$84.0
Today's High
$84.71
Today's Low
$83.46
Market Capitalization
$8.9B
Today's Volume
$368.6K
52 Week High
$93.45
52 Week Low
$58.925
Revenue TTM
$613.7M
EBITDA
$-121.1M
Earnings Per Share (EPS)
$-0.85
Profit Margin
-14.07%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-9.9%

How to invest in Intra-cellular Therapies, Inc. from India?

It is very easy for Indian residents to invest directly in Intra-cellular Therapies, Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Intra-cellular Therapies, Inc. stock in both rupees (INR) and dollars (USD). Search for Intra-cellular Therapies, Inc. or ITCI on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Intra-cellular Therapies, Inc. or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Intra-cellular Therapies, Inc. shares which would translate to 0.010 fractional shares of Intra-cellular Therapies, Inc. as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Intra-cellular Therapies, Inc.

33%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Intra-cellular Therapies, Inc. on INDmoney from India has grown in the last 30 days as on Dec 7, 2024. 33% more investors are searching Intra-cellular Therapies, Inc. in the last 30 days versus the previous period.

Global Institutional Holdings in Intra-cellular Therapies, Inc.

  • FMR Inc

    10.49%

  • Vanguard Group Inc

    9.08%

  • BlackRock Inc

    5.96%

  • JPMorgan Chase & Co

    4.99%

  • Wasatch Advisors LP

    3.63%

  • venBio Select Advisor LLC

    2.88%

Analyst Recommendation on Intra-cellular Therapies, Inc.

Buy

    86%Buy

    13%Hold

    0%Sell

Based on 23 Wall street analysts offering stock ratings for Intra-cellular Therapies, Inc.(by analysts ranked 0 to 5 stars)

Based on 23 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
20
19
20
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Intra-cellular Therapies, Inc.

What analysts predicted

Upside of 20.48%

Current:

$84.55

Target:

$101.87

Insights on Intra-cellular Therapies, Inc.

  • Increasing Revenue

    Revenue is up for the last 19 quarters, 882.51K → 175.15M (in $), with an average increase of 22.5% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -15.24M → -26.32M (in $), with an average decrease of 34.3% per quarter

  • Vs CTLT

    In the last 1 year, Catalent, Inc. has given 63.7% return, outperforming this stock by 26.9%

Intra-cellular Therapies, Inc. Technicals Summary

Sell

Neutral

Buy

Intra-cellular Therapies, Inc. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Intra-cellular Therapies, Inc. Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Intra-cellular Therapies, Inc.
Intra-cellular Therapies, Inc.
-5.98%
21.75%
39.48%
114.68%
628.05%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
0.89%
-6.15%
7.79%
50.04%
11.14%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
1.99%
16.11%
18.8%
31.31%
31.31%
Zoetis Inc.
Zoetis Inc.
2.58%
-2.27%
-5.33%
-23.89%
44.16%
Viatris Inc.
Viatris Inc.
11.02%
22.65%
31.13%
3.7%
-21.11%
Catalent, Inc.
Catalent, Inc.
3.62%
10.55%
67.08%
-51.26%
19.32%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Intra-cellular Therapies, Inc.
Intra-cellular Therapies, Inc.
NA
NA
0.0
-0.7
-0.1
-0.07
NA
10.8
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
33.98
33.98
0.3
6.54
0.16
0.12
NA
26.87
Haleon Plc Spon Ads
Haleon Plc Spon Ads
29.36
29.36
1.74
0.34
0.07
0.04
0.02
1.82
Zoetis Inc.
Zoetis Inc.
32.98
32.98
2.44
5.88
0.47
0.15
0.01
11.59
Viatris Inc.
Viatris Inc.
224.4
NA
0.08
2.67
-0.04
0.02
0.04
16.58
Catalent, Inc.
Catalent, Inc.
211.02
NA
514.17
0.2
-0.11
0.0
NA
19.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Intra-cellular Therapies, Inc.
Intra-cellular Therapies, Inc.
Buy
$8.9B
628.05%
NA
-14.07%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Buy
$12.9B
11.14%
33.98
17.21%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
Buy
$43.8B
31.31%
29.36
10.75%
Zoetis Inc.
Zoetis Inc.
Buy
$79.1B
44.16%
32.98
26.55%
Viatris Inc.
Viatris Inc.
Hold
$15.1B
-21.11%
224.4
-5.87%
Catalent, Inc.
Catalent, Inc.
Hold
$11.2B
19.32%
211.02
-9.34%

Intra-cellular Therapies, Inc. Dividend announcements

  • Intra-cellular Therapies, Inc. Earnings

    Intra-cellular Therapies, Inc.’s price-to-earnings ratio stands at None

    Read More

About Intra-cellular Therapies, Inc.

intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.
Organization
Intra-cellular Therapies, Inc.
Employees
610
CEO
Dr. Sharon Mates Ph.D.
Industry
Health Technology

Management People of Intra-cellular Therapies, Inc.

NameTitle
Dr. Sharon Mates Ph.D.
Co-Founder, Chairman & CEO
Mr. Michael I. Halstead J.D.
President
Dr. Suresh K. Durgam M.D.
Executive VP & Chief Medical Officer
Mr. Mark Neumann
EVP & Chief Commercial Officer
Dr. Robert E. Davis Ph.D.
Senior VP & Chief Scientific Officer
Mr. Juan Fernando Sanchez
Vice President of Corporate Communications & Investor Relations
Ms. Karen Patruno Sheehy Esq.
Senior VP & Chief Compliance Officer
John P. Condon
Senior Vice President, General Counsel & Secretary
Dr. Michael Olchaskey
Senior VP & Head of Regulatory Affairs
Mr. John A. Bardi
Senior VP of Market Access, Policy & Government Affairs

Important FAQs about investing in Intra-cellular Therapies, Inc. from India :

What is Intra-cellular Therapies, Inc. share price today?

Intra-cellular Therapies, Inc. (ITCI) share price today is $84.55.

Can Indians buy Intra-cellular Therapies, Inc. shares?

Yes, Indians can invest in the Intra-cellular Therapies, Inc. (ITCI) from India.

With INDmoney, you can buy Intra-cellular Therapies, Inc. at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Intra-cellular Therapies, Inc. at zero transaction cost.

How can I buy Intra-cellular Therapies, Inc. shares from India?

It is very easy to buy Intra-cellular Therapies, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Intra-cellular Therapies, Inc. be purchased?

Yes, you can buy fractional shares of Intra-cellular Therapies, Inc. with INDmoney app.

What are the documents required to start investing in Intra-cellular Therapies, Inc. stocks?

To start investing in Intra-cellular Therapies, Inc., You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Intra-cellular Therapies, Inc.

Today’s highest price of Intra-cellular Therapies, Inc. (ITCI) is $84.71.

Today’s lowest price of Intra-cellular Therapies, Inc. (ITCI) is $83.46.

What is today's market capitalisation of Intra-cellular Therapies, Inc.

Today's market capitalisation of Intra-cellular Therapies, Inc. ITCI is 8.9B

What is the 52 Week High and Low Range of Intra-cellular Therapies, Inc.

  • 52 Week High

    $93.45

  • 52 Week Low

    $58.93

How much percentage Intra-cellular Therapies, Inc. is down from its 52 Week High?

Intra-cellular Therapies, Inc. (ITCI) share price is $84.55. It is down by 99% from its 52 Week High price of $93.45.

How much percentage Intra-cellular Therapies, Inc. is up from its 52 Week low?

Intra-cellular Therapies, Inc. (ITCI) share price is $84.55. It is up by 1% from its 52 Week Low price of $58.93.

What are the historical returns of Intra-cellular Therapies, Inc.?

  • 1 Month Returns

    -5.98%

  • 3 Months Returns

    21.75%

  • 1 Year Returns

    39.48%

  • 5 Years Returns

    628.05%

Who is the Chief Executive Officer (CEO) of Intra-cellular Therapies, Inc.

Dr. Sharon Mates Ph.D. is the current Chief Executive Officer (CEO) of Intra-cellular Therapies, Inc..